🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesType 1.5 diabetes (LADA) and GLP-1 — what worked for you? Page 4

Type 1.5 diabetes (LADA) and GLP-1 — what worked for you?

pete_manc_UK Sun, Mar 16, 2025 at 5:43 AM 36 replies 2,172 viewsPage 4 of 8
Dr.PulmRoch
Member
456
2,345
Jun 2024
Rochester, MN
Mar 20, 2025 at 12:14 AM#16

From the other side of the consultation, briefly. The useful move here is to separate what is established from what is widely repeated. Those two sets overlap less than the confident tone of most write-ups suggests, and the second set is where nearly all the disagreement on this board comes from.

If somebody has the primary source to hand I would rather cite it than paraphrase it.

27 0rachel_ABQ, traveltech_sara, AttorneyGrant and 24 others
Reply Quote Save Share Report
MikeKY_noInsulin
Member
267
1,234
Oct 2024
Louisville, KY
Mar 20, 2025 at 1:53 PM#17
Dr.PulmRoch said:
The useful move here is to separate what is established from what is widely repeated.

Second this.

Last edited: Mar 20, 2025 at 4:53 PM
28 1hannah_MT, Dr.SportsMedIN, amy_econ_NJ and 25 others
Reply Quote Save Share Report
greg_boulder
Member
345
1,567
Jul 2024
Boulder, CO
Mar 21, 2025 at 3:33 AM#18
Dr.PulmRoch said:
The useful move here is to separate what is established from what is widely repeated.

Adding the part of the answer the thread has not reached. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

29 2Dr.DermMIA, fiona_VT, denise_HTX and 26 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PeptideChemSF
Senior Member
1,890
9,012
Jan 2024
San Francisco, CA
Mar 21, 2025 at 5:13 PM#19

One concrete data point for the thread. One habit that pays for itself: post the method alongside the number. A figure without its method cannot be checked, and an unchecked figure is how this community accumulates folklore.

Last edited: Mar 21, 2025 at 9:13 PM
30 3ricardo_MIA, BrianDallas92, labquiet_amy and 27 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Mar 22, 2025 at 6:53 AM#20

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part. Tagging this one for the weekly digest.

2 0PurityPaulOR, MaxMetOK
Reply Quote Save Share Report

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register